143 related articles for article (PubMed ID: 31207145)
1. RNA-Binding Motif Protein 6 is a Candidate Serum Biomarker for Pancreatic Cancer.
Duan B; Hu X; Fan M; Xiong X; Han L; Wang Z; Tong D; Liu L; Wang X; Li W; Yang J; Huang C
Proteomics Clin Appl; 2019 Sep; 13(5):e1900048. PubMed ID: 31207145
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers screening between preoperative and postoperative patients in pancreatic cancer.
Li P; Yang J; Ma QY; Wu Z; Huang C; Li XQ; Wang Z
Asian Pac J Cancer Prev; 2013; 14(7):4161-5. PubMed ID: 23991970
[TBL] [Abstract][Full Text] [Related]
3. Proteomic Profiling of Invasive Ductal Carcinoma (IDC) using Magnetic Beads-based Serum Fractionation and MALDI-TOF MS.
Yang J; Zhu J; He K; Zhao LY; Liu LY; Song TS; Huang C
J Clin Lab Anal; 2015 Jul; 29(4):321-7. PubMed ID: 25130542
[TBL] [Abstract][Full Text] [Related]
4. A Panel of Three Biomarkers Identified by iTRAQ for the Early Diagnosis of Pancreatic Cancer.
Wu X; Zhang ZX; Chen XY; Xu YL; Yin N; Yang J; Zhu DM; Li DC; Zhou J
Proteomics Clin Appl; 2019 Sep; 13(5):e1800195. PubMed ID: 31025496
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein C1 (APOC1), A Candidate Diagnostic Serum Biomarker for Breast Cancer Identified by Serum Proteomics Study.
Yan Y; Zhou Y; Wang K; Qiao Y; Zhao L; Chen M
Crit Rev Eukaryot Gene Expr; 2022; 32(4):1-9. PubMed ID: 35695660
[TBL] [Abstract][Full Text] [Related]
6. Detection and Identification of Serum Peptides Biomarker in Papillary Thyroid Cancer.
Lu ZL; Chen YJ; Jing XY; Wang NN; Zhang T; Hu CJ
Med Sci Monit; 2018 Mar; 24():1581-1587. PubMed ID: 29549708
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
[TBL] [Abstract][Full Text] [Related]
8. Isoform 1 of Fibrinogen Alpha Chain Precursor is a Potential Biomarker for Steroid-Induced Osteonecrosis of the Femoral Head.
Liu L; Song J; Li J; Huang N; Yang J; Hu S; Ma R; Wang W
Proteomics Clin Appl; 2020 Nov; 14(6):e1900099. PubMed ID: 32677377
[TBL] [Abstract][Full Text] [Related]
9. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
[TBL] [Abstract][Full Text] [Related]
10. Detection of pancreatic cancer using serum protein profiling.
Velstra B; Bonsing BA; Mertens BJ; van der Burgt YE; Huijbers A; Vasen H; Mesker WE; Deelder AM; Tollenaar RA
HPB (Oxford); 2013 Aug; 15(8):602-10. PubMed ID: 23458426
[TBL] [Abstract][Full Text] [Related]
11. SELDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of a boosting decision tree model for diagnosis of pancreatic cancer.
Qian JY; Mou SH; Liu CB
Asian Pac J Cancer Prev; 2012; 13(5):1911-5. PubMed ID: 22901146
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel serum peptides biomarkers for female breast cancer patients in Western China.
Yang J; Xiong X; Liu S; Zhu J; Luo M; Liu L; Zhao L; Qin Y; Song T; Huang C
Proteomics; 2016 Mar; 16(6):925-34. PubMed ID: 26705257
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.
Yang J; Yang J; Gao Y; Zhao L; Liu L; Qin Y; Wang X; Song T; Huang C
PLoS One; 2014; 9(11):e111364. PubMed ID: 25368985
[TBL] [Abstract][Full Text] [Related]
14. Identification of serum biomarkers for occupational medicamentosa-like dermatitis induced by trichloroethylene using mass spectrometry.
Hong WX; Liu W; Zhang Y; Huang P; Yang X; Ren X; Ye J; Huang H; Tang H; Zhou G; Huang X; Zhuang Z; Liu J
Toxicol Appl Pharmacol; 2013 Nov; 273(1):121-9. PubMed ID: 23994554
[TBL] [Abstract][Full Text] [Related]
15. Identification of urinary biomarkers for type 2 diabetes using bead-based proteomic approach.
Chu L; Fu G; Meng Q; Zhou H; Zhang M
Diabetes Res Clin Pract; 2013 Aug; 101(2):187-93. PubMed ID: 23769013
[TBL] [Abstract][Full Text] [Related]
16. A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline.
Liu X; Zheng W; Wang W; Shen H; Liu L; Lou W; Wang X; Yang P
Br J Cancer; 2017 Dec; 117(12):1846-1854. PubMed ID: 29123261
[TBL] [Abstract][Full Text] [Related]
17. Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis.
Guo J; Wang W; Liao P; Lou W; Ji Y; Zhang C; Wu J; Zhang S
Cancer Sci; 2009 Dec; 100(12):2292-301. PubMed ID: 19775290
[TBL] [Abstract][Full Text] [Related]
18. Application Value of Mass Spectrometry in the Differentiation of Benign and Malignant Liver Tumors.
Li B; Li B; Guo T; Sun Z; Li X; Li X; Wang H; Chen W; Chen P; Qiao M; Xia L; Mao Y
Med Sci Monit; 2017 Apr; 23():1636-1644. PubMed ID: 28376075
[TBL] [Abstract][Full Text] [Related]
19. LC-MS/MS and SWATH based serum metabolomics enables biomarker discovery in pancreatic cancer.
Xiong Y; Shi C; Zhong F; Liu X; Yang P
Clin Chim Acta; 2020 Jul; 506():214-221. PubMed ID: 32243985
[TBL] [Abstract][Full Text] [Related]
20. Proteomic Screening for Serum Biomarkers for Cervical Cancer and Their Clinical Significance.
Chen Y; Xiong X; Wang Y; Zhao J; Shi H; Zhang H; Wang Y; Wei Y; Xue W; Zhang J
Med Sci Monit; 2019 Jan; 25():288-297. PubMed ID: 30625128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
